Italy, Oct. 21 -- Italy based Exeltis Italia srl has secured contract from SCR PIEMONTE SPA for Various medicinal products - Centralized regional tender for the stipulation of a framework agreement for the supply of medicines based on Denosumab, Etanercept, Adalimumab, Pegfilgrastim, Enoxaparin Sodica, Aflibercept, Ranibizumab and related services. The value of the contract is worth 1081520.43 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....